세계의 말더듬 치료 기기 시장(2023-2030년)

Overview

Stuttering is also known as disfluency, stammering or childhood-onset fluency disorder. It is a speech disorder that involves frequent and significant problems with normal fluency and flow of speech. People who stutter know what they want to say, but have difficulty saying it. This disrupts the flow of speech and causes pauses, unintended sounds and sticking on words. This condition usually affects children but can have impacts at any age. It's a treatable condition.

Moreover, electronic fluency devices, communication devices, speech-generating devices, hearing aids and anti-stammering devices are commonly used in stuttering to improve speech fluency. Electronic fluency devices also known as assistive devices, electronic aids, altered auditory and feedback devices are electronic devices intended to improve fluency for stuttering patients. Most electronic fluency devices change the sound of the user's voice in the patient's ear. Communication devices and speech-generating devices helps to verbally communicate with ease and increase efficiency.

Market Dynamics: Drivers

Increasing adoption of technologically advanced devices

The increasing adoption of technologically advanced devices are expected to drive the market over the forecast period. Continuous advancements in technology, including artificial intelligence (AI), virtual reality (VR), and wearable devices, offer new and innovative solutions for stuttering therapy with advanced and comfortable features. These technologies can provide personalized exercises and immersive experiences, enhancing the effectiveness of speech therapy by using these advanced devices.

For instance, on June 08, 2023, AONDevices launched its AONDenoise, a compact, efficient edge AI denoising technology designed for applications that require minimal power and latency. AONDenoise has 50K parameters, making it one of the smallest denoising algorithms available, and ideal AI speech enhancement for use in hearing aids, wireless earbuds and wearables.

Moreover, advanced devices often come with user-friendly interfaces, making them accessible and easy to use for individuals seeking speech therapy. The improved user experience can contribute to higher adoption of these devices. Advanced devices can use artificial intelligence to analyze individual speech patterns and customize treatment plans. Personalized therapy approaches are often more effective in addressing the unique needs of each person who are suffering from stuttering.

In Addition, the advancements in communication devices like augmentative and alternative communication devices are most likely to improve the adoption of the devices in speech therapy. As more research is conducted on the efficacy of technologically advanced stuttering devices, healthcare professionals may be more aware of integrating these devices into their treatment plans.

For instance, on September 1, 2020, Control Bionics released the newest addition to its Augmentative and Alternative Communication (AAC) device line, the GridPad Trilogy communication solution. Offering touch control, eye control, and NeuroNode 3.0 control within the same system, the GridPad Trilogy is a unique 3-in-1 AAC device that progresses and grows with clients and their abilities. It allows for faster communication, at rates up to 133 percent that of other systems.

Further, the increasing prevalence of stuttering mostly in children, increasing clinical trials to develop more appropriate devices, increasing awareness about the speech therapy devices and advancements in the development of novel devices are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications and risks associated with the use of stuttering devices, the high cost of the devices and these devices also do not work well when the person is frequently speaking in environments with significant background noise are expected to hamper the market.

Segment Analysis

The global stuttering devices market is segmented based on disease type, device type, end-user and region.

The electronic fluency devices segment accounted for approximately 37.8% of the inflammatory myositis treatment market share

The electronic fluency devices segment is expected to hold the largest market share over the forecast period. Many electronic fluency devices are known to provide real-time auditory feedback to individuals who are suffering from stuttering. This feedback can include altered auditory feedback, which involves modifying the individual's own speech and playing it back in real-time. This process can help individuals become more aware of their speech patterns and make conscious adjustments to improve fluency by avoiding the stuttering.

Additionally, many electronic fluency devices are designed to be portable and discreet. This allows individuals to incorporate the use of these devices into their daily lives without drawing significant attention. Portable devices are particularly convenient for those who want to practice fluency techniques in various settings. These devices can be used in homecare settings according to the patient's priority.

Moreover, these electronic fluency devices either delay or alter the sound of one's voice, creating an echo, or playing some sort of noise, both of which are known to reduce stuttering. However, it is also known that the effects may wear off over time.

Geographical Analysis

North America accounted for approximately 40.1% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of the devices. North America especially the United States is known for its strong presence of major players such as biotechnology companies and medical device companies which are focussing on the development of the more advanced devices. The presence of major players actively focussing on developing the devices for stuttering.

For instance, on April 14, 2020, the Learning Corp, an award-winning digital therapeutics provider, cleared that it had received Breakthrough Device designation from the United States Food and Drug Administration (FDA) for its Speech Therapy, which is designed to provide accessible cognitive, speech and language therapy to stroke patients.

Moreover, the increasing prevalence of stuttering cases in the region is expected to increase the adoption of stuttering devices in speech therapy. For instance, according to the Stuttering Foundation of America, There are 3 million people in the United States suffering from stuttering. This increasing prevalence is increasing the demand for stuttering devices.

Competitive Landscape

The major global players in the stuttering devices market include: Takalam Tech, Casa Futura Technologies, SpeechEasy, Tobii Dynavox AB, PRC-Saltillo, DrSpectra, Attainment Company, Inc., Lingraphica, Numotion and AbleNet, Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global stuttering devices market. The pandemic led to disruptions in global supply chains, affecting the production and distribution of stuttering devices. The pandemic accelerated the adoption of telehealth services. While this shift facilitated the remote healthcare consultations, it also influenced the types of interventions and devices that could be effectively utilized during virtual sessions, potentially impacting the use of certain stuttering devices.

Market Segmentation

By Disease Type

• Developmental Stuttering (Child-Onset Fluency Disorder)
• Persistent Stuttering
• Acquired Stuttering
  • Neurogenic Stuttering
  • Psychogenic Stuttering

By Device Type

• Electronic Fluency Devices
• Communication Devices
• Speech Generating Devices
• Hearing Aids
• Others

By End-User

• Hospitals
• Specialty Clinics
• Speech Therapy Centers
• Homecare Settings
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report?

• To visualize the global stuttering devices market segmentation based on disease type, device type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of stuttering devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global stuttering devices market report would provide approximately 61 tables, 61 figures, and 187 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Disease Type
• 3.2. Snippet by Device Type
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Adoption of Stuttering Devices
  • 4.1.2. Restraints
    • 4.1.2.1. Complications and Risks Associated with the Devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Pipeline Analysis
• 5.6. Unmet Needs
• 5.7. Patent Analysis
• 5.8. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Disease Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 7.1.2. Market Attractiveness Index, By Disease Type
• 7.2. Developmental Stuttering (Child-Onset Fluency Disorder) *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Persistent Stuttering
• 7.4. Acquired Stuttering
  • 7.4.1. Neurogenic Stuttering
  • 7.4.2. Psychogenic Stuttering

8. By Device Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 8.1.2. Market Attractiveness Index, By Device Type
• 8.2. Electronic Fluency Devices*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Communication Devices
• 8.4. Speech Generating Devices
• 8.5. Hearing Aids
• 8.6. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Speech Therapy Centers
• 9.5. Homecare Settings
• 9.6. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Takalam Tech*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Casa Futura Technologies
• 12.3. SpeechEasy
• 12.4. Tobii Dynavox AB
• 12.5. PRC-Saltillo
• 12.6. DrSpectra
• 12.7. Attainment Company, Inc.
• 12.8. Lingraphica
• 12.9. Numotion
• 12.10. AbleNet, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us